These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 19579180

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK, Lee CH, Choi HS.
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.
    Grempler R, Kienitz A, Werner T, Meyer M, Barthel A, Ailett F, Sutherland C, Walther R, Schmoll D.
    Biochem J; 2004 Sep 01; 382(Pt 2):471-9. PubMed ID: 15167811
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells.
    Chen R, Meseck M, McEvoy RC, Woo SL.
    Gene Ther; 2000 Nov 01; 7(21):1802-9. PubMed ID: 11110411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF.
    Diabetes Metab; 1999 Jun 01; 25(2):110-27. PubMed ID: 10443322
    [Abstract] [Full Text] [Related]

  • 11. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
    Yuan HD, Piao GC.
    Biosci Biotechnol Biochem; 2011 Jun 01; 75(6):1079-84. PubMed ID: 21670525
    [Abstract] [Full Text] [Related]

  • 12. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T, Okuno A, Tanaka J, Takahashi K, Nakashima R, Kanda S, Ogawa J, Hagisawa Y, Fujiwara T.
    Eur J Pharmacol; 2009 Nov 25; 623(1-3):141-7. PubMed ID: 19765581
    [Abstract] [Full Text] [Related]

  • 13. Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase.
    Ohira M, Miyashita Y, Murano T, Watanabe F, Shirai K.
    Metabolism; 2009 Oct 25; 58(10):1408-14. PubMed ID: 19570550
    [Abstract] [Full Text] [Related]

  • 14. Tumour necrosis factor-alpha attenuates insulin action on phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis by altering the cellular localization of Foxa2 in HepG2 cells.
    Pandey AK, Bhardwaj V, Datta M.
    FEBS J; 2009 Jul 25; 276(14):3757-69. PubMed ID: 19769745
    [Abstract] [Full Text] [Related]

  • 15. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
    Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM.
    Diabetes; 2008 May 25; 57(5):1414-8. PubMed ID: 18285556
    [Abstract] [Full Text] [Related]

  • 16. Metformin induces suppression of NAD(P)H oxidase activity in podocytes.
    Piwkowska A, Rogacka D, Jankowski M, Dominiczak MH, Stepiński JK, Angielski S.
    Biochem Biophys Res Commun; 2010 Mar 05; 393(2):268-73. PubMed ID: 20123087
    [Abstract] [Full Text] [Related]

  • 17. Chronic activation of AMP-activated kinase as a strategy for slowing aging.
    McCarty MF.
    Med Hypotheses; 2004 Mar 05; 63(2):334-9. PubMed ID: 15236799
    [Abstract] [Full Text] [Related]

  • 18. The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells.
    Purushotham A, Tian M, Belury MA.
    Mol Nutr Food Res; 2009 Feb 05; 53(2):300-7. PubMed ID: 19035551
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional mechanism of suppression of insulin gene expression by AMP-activated protein kinase activator 5-amino-4-imidazolecarboxamide riboside (AICAR) in beta-cells.
    Kim JW, Cho JH, Ko SH, Park HS, Ha J, Song KH, Son HY, Kim SS, Yoon KH, Suh-Kim H.
    Biochem Biophys Res Commun; 2008 Jan 25; 365(4):614-20. PubMed ID: 18035054
    [Abstract] [Full Text] [Related]

  • 20. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
    Cho CY, Koo SH, Wang Y, Callaway S, Hedrick S, Mak PA, Orth AP, Peters EC, Saez E, Montminy M, Schultz PG, Chanda SK.
    Cell Metab; 2006 May 25; 3(5):367-78. PubMed ID: 16679294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.